華大基因(300676.SZ)近期股價漲幅較大 子公司獲三個新冠病毒檢測相關產品註冊證
格隆匯2月3日丨華大基因(300676.SZ)公佈,公司股票連續2個交易日(2020年1月23日、2020年2月3日)累計漲幅達16.71%。
近期,新型冠狀病毒性肺炎疫情在全國範圍內出現並引起社會廣泛關注。公司新型冠狀病毒2019-nCoV核酸檢測試劑盒(熒光PCR法)、新型冠狀病毒2019-nCoV核酸檢測試劑盒(聯合探針錨定聚合測序法)與新型冠狀病毒2019-nCoV核酸分析軟件於2020年1月26日獲得國家藥品監督管理局(“國家藥監局”)頒發的醫療器械註冊證,成為首批正式獲准上市的抗擊冠狀病毒疫情的檢測產品之一。上述檢測產品可用於測定疑似患者的樣本中是否有新型冠狀病毒,有利於快速辨別感染人羣,滿足病毒診斷的應急使用,為疫情防控提供保障。為積極踐行企業社會責任、支持疫情防控工作的開展,公司已決定向武漢市和湖北省共計捐贈2萬人份新型冠狀病毒檢測試劑盒,相關批次正在陸續送達;此外公司還將聯合各界愛心機構及人士追加捐贈10萬人份檢測試劑盒。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.